Pfizer vaccine safe after myocarditis, study confirms

No patient who'd been admitted with the condition previously had a repeat episode following mRNA vaccination, researchers say at ESC event

GPs can be reassured that patients who have had myocarditis in the past can safety receive the Pfizer-BioNTech coronavirus vaccine without causing the problem to recur, according to a new small study.

Rare cases of myocarditis following mRNA COVID-19 vaccination, primarily in young males after the second dose, have been reported in the medical literature.

ATAGI guidance published in November last year says patients with myocarditis or pericarditis in the last three months due to causes other than